Meet One of Our Global Heath Fellows: Clarisse Casilang, MD
Sep 12, 2022
Clarisse Casilang, MD, is a board-certified general pediatrician and a fellow of the American Academy of Pediatrics.
<p>Brachial plexus and peripheral nerve injuries affect the nerves that supply the arms and hands, and include birth-related palsies, trauma and peripheral tumors.</p>
Sep 12, 2022
Clarisse Casilang, MD, is a board-certified general pediatrician and a fellow of the American Academy of Pediatrics.
Sep 13, 2022
The new relationship brings CHOP’s world-class pediatric healthcare to patients and families across the award-winning Main Line Health System.
Sep 6, 2022
CHOP researchers have used advanced 3D mapping techniques to identify genetic variants and corresponding target genes in the pancreas that are implicated in type 2 diabetes.
Sep 8, 2022
Here, Arun K. Srinivasan, MD, MRCS, shares how his upbringing in India influenced his career path, and he discusses how racial disparities in medicine can be addressed.
Sep 2, 2022
Dr. Sandra Amaral, attending physician in CHOP’s Division of Nephrology and the Kidney Transplant and Dialysis Program, led a study recently published in JAMA that found an association between dialysis facility ownership and access to the waiting list and transplant in pediatric patients with end-stage kidney disease in the United States. The findings were covered in this Kaiser Health News article.
Sep 1, 2022
A new study by a multi-institutional group of pediatric cancer researchers, including those at CHOP, has characterized the genomic landscape for acute lymphoblastic leukemia.
Aug 31, 2022
First-of-its-kind study identifies differences between sexes as well as ethnic background.
Aug 31, 2022
CBS Philadelphia Features Dr. Gregory Tasian on rising temperatures and climate change may lead to increased risk of kidney stones.
Aug 31, 2022
Variants of the FBXL4 gene cause a severe form of the disorder with many complications and no approved treatment options.
Aug 29, 2022
New study shows how nicotimamide riboside, part of the vitamin B3 family, could mitigate myopathy caused by a genetic variant.